FAQ/Help |
Calendar |
Search |
Today's Posts |
08-25-2017, 02:00 AM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
Smarter Analyst Adamas Pharma shares soar on Parkinson's dyskinesia drug approval MarketWatch Adamas Pharmaceuticals Inc. ADMS, -1.11% shares soared after the drug maker received Food and Drug Administration approval for a one-of-a-kind treatment for the involuntary movements associated with Parkinson's disease. Adamas shares jumped 36% ... Adamas Pharma secures approval for Parkinson's dyskinesia drugReuters Adamas wins its first FDA OK, setting up market launch for a ...Endpoints News ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira BiosimMarkets Insider StreetInsider.com -Smarter Analyst -MD Magazine (registration) (blog) all 9 news articles » More... |
||
Reply With Quote |
Reply |
|
|